NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.60 | $-0.30 | -100.0 % |
Jun 2024 | 2024-08-13 | $-1.37 | $-1.23 | -11.4 % |
Mar 2024 | 2024-05-09 | $-4.90 | $-5.25 | 6.67 % |
Dec 2023 | 2024-03-26 | $-7.35 | $-10.50 | 30.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $2.44M | $2.62M | -6.94 % |
Jun 2024 | 2024-08-13 | $2.40M | $3.15M | -23.8 % |
Mar 2024 | 2024-05-09 | $2.63M | $3.28M | -19.8 % |
Dec 2023 | 2024-03-26 | $3.73M | $3.40M | 9.62 % |
NovaBay Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
NovaBay Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.60, which missed the estimate of $-0.30.
NovaBay Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.